Treatment of neovascular age-related macular degeneration with anti-vascular endothelial growth factor drugs: progress from mechanisms to clinical applications

被引:1
|
作者
Cheng, Shizhou [1 ]
Zhang, Shu [1 ]
Huang, Mingyan [1 ]
Liu, Yuxuan [1 ]
Zou, Xunyu [1 ]
Chen, Xiaoming [1 ]
Zhang, Zuhai [1 ]
机构
[1] Yangtze Univ, Dept Ophthalmol, Affiliated Hosp 1, Jingzhou, Peoples R China
关键词
neovascular age-related macular degeneration; vascular endothelial growth factor; treatment; mechanism; clinical application; INTRAVITREAL AFLIBERCEPT INJECTION; RANIBIZUMAB; THERAPY; VEGF; ANGIOGENESIS; OUTCOMES; PHARMACOKINETICS; CLASSIFICATION; DISCOVERY; HISTORY;
D O I
10.3389/fmed.2024.1411278
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neovascular age-related macular degeneration (nARMD) is an important cause of visual impairment and blindness in the elderly, with choroidal neovascularization in the macula as the main pathological feature. The onset of nARMD is closely related to factors including age, oxidative stress, and lipid metabolism. Vascular endothelial growth factor (VEGF) is an important factor contributing to nARMD as well as choroidal neovascularization and retinal leakage formation. At present, anti-VEGF therapy is the only treatment that improves vision and halts disease progression in most patients, making anti-VEGF drugs a landmark development for nARMD treatment. Although intravitreal injection of anti-VEGF drugs has become the first-line treatment for nARMD, this treatment has many shortcomings including repeated injections, poor or no response in some patients, and complications such as retinal fibrosis. As a result, several new anti-VEGF drugs are being developed. This review provides a discussion of these new anti-VEGF drugs for the treatment of nARMD.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Switching Anti-Vascular Endothelial Growth Factors in Refractory Neovascular Age-Related Macular Degeneration
    Ashraf, Mohammed
    Banaee, Touka
    Silva, Fabiana Q.
    Singh, Rishi P.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2018, 49 (03): : 166 - +
  • [42] Simulating an Anti-Vascular Endothelial Growth Factor Switch in Neovascular Age-Related Macular Degeneration A HARBOR Subanalysis
    Zarbin, Marco
    Tsuboi, Min
    Hill, Lauren F.
    Stoilov, Ivaylo
    OPHTHALMOLOGY, 2019, 126 (06) : 849 - 855
  • [43] Effects of delay in anti-vascular endothelial growth factor intravitreal injections for neovascular age-related macular degeneration
    Hanhart, Joel
    Wiener, Rony
    Totah, Hashem
    Gelman, Evgeny
    Weill, Yishay
    Abulafia, Adi
    Zadok, David
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (06) : 1907 - 1914
  • [44] Aflibercept anti-vascular endothelial growth factor therapy in vitrectomized eyes with neovascular age-related macular degeneration
    Jung, Jesse J.
    Hoang, Quan V.
    Arain, Mohammad Z. Y.
    Chang, Stanley
    ACTA OPHTHALMOLOGICA, 2016, 94 (03) : E249 - E250
  • [45] Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration
    Veloso, Carlos E.
    Kanadani, Tereza M.
    Pereira, Frederico B.
    Nehemy, Marcio B.
    OPHTHALMOLOGY, 2015, 122 (08) : 1569 - 1572
  • [46] Anti-vascular endothelial growth factor for neovascular age-related macular degeneration in 2022: Same, same but different
    Fung, Adrian T.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 50 (03): : 270 - 273
  • [47] Endophthalmitis Following Intravitreal Anti-Vascular Endothelial Growth Factor Injections for Neovascular Age-Related Macular Degeneration
    Moshfeghi, Andrew A.
    SEMINARS IN OPHTHALMOLOGY, 2011, 26 (03) : 139 - 148
  • [48] Geographic Atrophy in Patients Receiving Anti-Vascular Endothelial Growth Factor for Neovascular Age-Related Macular Degeneration
    Xu, Luna
    Mrejen, Sarah
    Jung, Jesse J.
    Gallego-Pinazo, Roberto
    Thomson, Desmond
    Marsiglia, Marcela
    Boddu, Sucharita
    Freund, K. Bailey
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [49] Understanding Variation in Response to Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration
    Maguire, Maureen G.
    JAMA OPHTHALMOLOGY, 2018, 136 (08) : 884 - 885
  • [50] Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration The Comparison of Age-Related Macular Degeneration Treatments Trials
    Maguire, Maureen G.
    Martin, Daniel F.
    Ying, Gui-shuang
    Jaffe, Glenn J.
    Daniel, Ebenezer
    Grunwald, Juan E.
    Toth, Cynthia A.
    Ferris, Frederick L., III
    Fine, Stuart L.
    OPHTHALMOLOGY, 2016, 123 (08) : 1751 - 1761